المؤلفون: Ojaimi S., Purcell R., Doherty R.

مصطلحات الفهرس: highly active antiretroviral therapy, human, Human immunodeficiency virus infection/di [Diagnosis], Human immunodeficiency virus infection/dt [Drug Therapy], Human immunodeficiency virus infection/pc [Prevention], hypoxic ischemic encephalopathy/co [Complication], infection prevention, infection risk, letter, liver toxicity/si [Side Effect], mixed infection/pc [Prevention], monotherapy, newborn, opportunistic infection/co [Complication], patient attitude, perinatal infection/co [Complication], prematurity/co [Complication], priority journal, protein function, syphilis, tuberculosis/dt [Drug Therapy], virus load, antiretrovirus agent/it [Drug Interaction], antiretrovirus agent/dt [Drug Therapy], cytochrome P450/ec [Endogenous Compound], isoniazid/cb [Drug Combination], isoniazid/it [Drug Interaction], isoniazid/dt [Drug Therapy], lamivudine/dt [Drug Therapy], lamivudine/pk [Pharmacokinetics], nevirapine/ae [Adverse Drug Reaction], nevirapine/cr [Drug Concentration], nevirapine/do [Drug Dose], nevirapine/it [Drug Interaction], nevirapine/dt [Drug Therapy], nevirapine/ig [Intragastric Drug Administration], nevirapine/pk [Pharmacokinetics], rifampicin/cb [Drug Combination], rifampicin/it [Drug Interaction], rifampicin/dt [Drug Therapy], virus DNA/ec [Endogenous Compound], virus RNA/ec [Endogenous Compound], zidovudine/it [Drug Interaction], zidovudine/dt [Drug Therapy], zidovudine/iv [Intravenous Drug Administration], zidovudine/pk [Pharmacokinetics], AIDS patient, cytomegalovirus infection, disease severity, disease transmission, drug absorption, drug clearance, drug dose titration, drug metabolism, female, gastrointestinal absorption, genotype, gestational age, high risk patient, Letter

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/28867
Journal of Paediatrics and Child Health
Click here for full text options
LibKey Link

المؤلفون: Teh J., Murphy D.G., Azad A., Siva S., Alghazo O., Sathianathen N., Thangasamy I.A., Kwan E.M.

مصطلحات الفهرس: ischemic heart disease/si [Side Effect], liver toxicity/si [Side Effect], low drug dose, note, practice guideline, priority journal, prostate cancer/dt [Drug Therapy], quality of life, rash/si [Side Effect], risk reduction, seizure/si [Side Effect], survival time, systemic therapy, urologist, abiraterone/ae [Adverse Drug Reaction], abiraterone/cb [Drug Combination], abiraterone/dt [Drug Therapy], overall survival, prednisone/cb [Drug Combination], prednisone/do [Drug Dose], prednisone/dt [Drug Therapy], metastatic hormone sensitive prostate cancer/dt [Drug Therapy], androgen deprivation therapy, cancer combination chemotherapy, cancer survival, cognitive defect/si [Side Effect], dose response, drug efficacy, drug monitoring, drug safety, fatigue/si [Side Effect], human, hyperglycemia/si [Side Effect], hypertension/si [Side Effect], hypokalemia/si [Side Effect], hypothyroidism/si [Side Effect], abiraterone/po [Oral Drug Administration], apalutamide/ae [Adverse Drug Reaction], apalutamide/dt [Drug Therapy], apalutamide/po [Oral Drug Administration], docetaxel/dt [Drug Therapy], enzalutamide/ae [Adverse Drug Reaction], enzalutamide/dt [Drug Therapy], enzalutamide/po [Oral Drug Administration], prednisolone/ae [Adverse Drug Reaction], prednisolone/dt [Drug Therapy], Note

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/35405
BJU International
Click here for full text options
LibKey Link

المؤلفون: Chew C.Y., Saracino A.M., Nikpour M., Mar A.

مصطلحات الفهرس: drug absorption, drug bioavailability, drug contraindication, drug efficacy, drug metabolism, drug safety, erythema annulare centrifugum/si [Side Effect], erythema multiforme/si [Side Effect], eye examination, gastrointestinal symptom/si [Side Effect], giant cell granuloma/dt [Drug Therapy], glioblastoma/dt [Drug Therapy], glucose 6 phosphate dehydrogenase deficiency, granuloma annulare/dt [Drug Therapy], heart protection, heartburn/si [Side Effect], human, hyperpigmentation/si [Side Effect], hypertransaminasemia/si [Side Effect], hypoglycemia/si [Side Effect], immunomodulation, irritability, leukopenia/si [Side Effect], lichen (disease)/dt [Drug Therapy], lichen planus/dt [Drug Therapy], lichen sclerosus et atrophicus/dt [Drug Therapy], liver toxicity/si [Side Effect], lung cancer/dt [Drug Therapy], lupus vulgaris/dt [Drug Therapy], measles like rash/si [Side Effect], melanoma/dt [Drug Therapy], mood change, morphea/dt [Drug Therapy], mucinosis/dt [Drug Therapy], multiple myeloma/dt [Drug Therapy], nausea/si [Side Effect], necrobiosis lipoidica/dt [Drug Therapy], nightmare/si [Side Effect], nonhuman, outcome assessment, pancreas cancer/dt [Drug Therapy], panniculitis/dt [Drug Therapy], patient monitoring, pharmacodynamics, photodermatosis/dt [Drug Therapy], porphyria cutanea tarda/dt [Drug Therapy], practice guideline, pregnancy, prescription, pruritus/si [Side Effect], psoriasis/si [Side Effect], rash/si [Side Effect], retina maculopathy/si [Side Effect], retinopathy/si [Side Effect], review, risk benefit analysis, risk reduction, sarcoma/dt [Drug Therapy], side effect/si [Side Effect], skin contusion/si [Side Effect], skin sarcoidosis/dt [Drug Therapy], smoking, solid malignant neoplasm/dt [Drug Therapy], Stevens Johnson syndrome/si [Side Effect], systemic lupus erythematosus/dt [Drug Therapy], systemic sclerosis/dt [Drug Therapy], toxic epidermal necrolysis/si [Side Effect], treatment response, urticaria/si [Side Effect], vasculitis/dt [Drug Therapy], visual impairment/si [Side Effect], vomiting/si [Side Effect], cyclosporine/it [Drug Interaction], digoxin/it [Drug Interaction], glucose 6 phosphate dehydrogenase/ec [Endogenous Compound], hydroxychloroquine/ae [Adverse Drug Reaction], hydroxychloroquine/it [Drug Interaction], hydroxychloroquine/dt [Drug Therapy], hydroxychloroquine/pk [Pharmacokinetics], hydroxychloroquine/pd [Pharmacology], methotrexate/it [Drug Interaction], follicular mucinosis/dt [Drug Therapy], lichen planopilaris/dt [Drug Therapy], reticular erythematous mucinosis/dt [Drug Therapy], urticarial vasculitis/dt [Drug Therapy], laboratory test, abdominal distension/si [Side Effect], acute generalized exanthematous pustulosis/si [Side Effect], agranulocytosis/si [Side Effect], alopecia/si [Side Effect], alopecia areata/dt [Drug Therapy], anorexia/si [Side Effect], antineoplastic activity, antiphospholipid syndrome/dt [Drug Therapy], antithrombotic activity, aplastic anemia/si [Side Effect], blood toxicity/si [Side Effect], chronic urticaria/dt [Drug Therapy], dermatology, dermatomyositis/dt [Drug Therapy], diarrhea/si [Side Effect], DRESS syndrome/si [Side Effect], Review

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/35375
Australasian Journal of Dermatology
Click here for full text options
LibKey Link

المؤلفون: Sander P., Chu V.H., Durack D.T., Fortes C.Q., Fowler V., Krachmer A.W., Wilson W.R., Stewart R., Herwaldt L.A., Widmer A., Brown Elliot B.A., Falk V., Halbe M., Scriven J.E., Sax H., van Ingen J., Mestres C.A., Diekema D., Brown-Elliott B.A., Wallace R.J., Baddour L.M., Miro J.M., Hoen B., Athan E., Bayer A., Barsic B., Stuart R.L., Hasse B., Hannan M.M., Keller P.M., Maurer F.P., Sommerstein R., Mertz D., Wagner D., Fernandez-Hidalgo N., Nomura J., Manfrin V., Bettex D., Hernandez Conte A., Durante-Mangoni E., Tang T.H.-C., Lundgren J., Gordon S., Jarashow M.C., Schreiber P.W., Niemann S., Kohl T.A., Daley C.L., Stewardson A.J., Whitener C.J., Perkins K., Plachouras D., Lamagni T., Chand M., Freiberger T., Zweifel S., Corey G.R., Schulthess B.

مصطلحات الفهرس: patient care, perfusionist, perioperative period, peripheral neuropathy/si [Side Effect], positron emission tomography-computed tomography, postoperative infection/co [Complication], postoperative infection/di [Diagnosis], postoperative infection/dt [Drug Therapy], postoperative infection/pc [Prevention], postoperative infection/su [Surgery], practice guideline, preoperative care, prognosis, public health, QT prolongation/si [Side Effect], risk factor, short survey, skin discoloration/si [Side Effect], surgical approach, transesophageal echocardiography, tremor/si [Side Effect], tuberculosis/co [Complication], tuberculosis/di [Diagnosis], tuberculosis/dt [Drug Therapy], tuberculosis/pc [Prevention], tuberculosis/su [Surgery], whole genome sequencing, amikacin/dt [Drug Therapy], azithromycin/ae [Adverse Drug Reaction], azithromycin/dt [Drug Therapy], bedaquiline/ae [Adverse Drug Reaction], bedaquiline/dt [Drug Therapy], clarithromycin/ae [Adverse Drug Reaction], clarithromycin/dt [Drug Therapy], clofazimine/ae [Adverse Drug Reaction], clofazimine/dt [Drug Therapy], ethambutol/ae [Adverse Drug Reaction], ethambutol/dt [Drug Therapy], linezolid/ae [Adverse Drug Reaction], linezolid/dt [Drug Therapy], moxifloxacin/ae [Adverse Drug Reaction], moxifloxacin/dt [Drug Therapy], rifabutin/ae [Adverse Drug Reaction], rifabutin/dt [Drug Therapy], rifampicin/ae [Adverse Drug Reaction], rifampicin/dt [Drug Therapy], tuberculostatic agent/dt [Drug Therapy], medical device, abnormal body build/si [Side Effect], abdominal pain/si [Side Effect], antimicrobial therapy, arthralgia/si [Side Effect], bloating/si [Side Effect], bone marrow suppression/si [Side Effect], cardiac surgeon, cardiopulmonary bypass, cardiovascular infection/co [Complication], cardiovascular infection/di [Diagnosis], cardiovascular infection/dt [Drug Therapy], cardiovascular infection/pc [Prevention], cardiovascular infection/su [Surgery], chorioretinitis/co [Complication], chorioretinitis/di [Diagnosis], chorioretinitis/pc [Prevention], chorioretinitis/su [Surgery], clinical feature, conflict of interest, diagnostic imaging, diarrhea/si [Side Effect], dizziness/si [Side Effect], drug fever/si [Side Effect], drug hypersensitivity/si [Side Effect], drug induced disease, drug monitoring, early diagnosis, electrolyte disturbance/si [Side Effect], eye disease/si [Side Effect], eye examination, eye infection/co [Complication], eye infection/di [Diagnosis], eye infection/dt [Drug Therapy], eye infection/pc [Prevention], eye infection/su [Surgery], flu like syndrome/si [Side Effect], follow up, gastrointestinal symptom/si [Side Effect], gastrointestinal toxicity/si [Side Effect], headache/si [Side Effect], hearing impairment/si [Side Effect], high risk population, histopathology, hospital patient, human, immune reconstitution inflammatory syndrome/co [Complication], immune reconstitution inflammatory syndrome/di [Diagnosis], immune reconstitution inflammatory syndrome/pc [Prevention], infection control, infection prevention, infection risk, infectious disease specialist, insomnia/si [Side Effect], iridocyclitis/si [Side Effect], jaundice/si [Side Effect], laboratory test, lactic acidosis/si [Side Effect], liver toxicity/si [Side Effect], medical society, microbiological examination, microbiology, molecular diagnosis, morbidity, mortality, multidisciplinary team, Mycobacterium chimaera, myopathy/si [Side Effect], nausea/si [Side Effect], neurologic disease/si [Side Effect], ophthalmologist, pancreatitis/si [Side Effect], Short Survey

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/28913
Journal of Hospital Infection
Click here for full text options
LibKey Link

المؤلفون: Ojaimi S., Purcell R., Doherty R.

مصطلحات الفهرس: highly active antiretroviral therapy, human, Human immunodeficiency virus infection/di [Diagnosis], Human immunodeficiency virus infection/dt [Drug Therapy], Human immunodeficiency virus infection/pc [Prevention], hypoxic ischemic encephalopathy/co [Complication], infection prevention, infection risk, letter, liver toxicity/si [Side Effect], mixed infection/pc [Prevention], monotherapy, newborn, opportunistic infection/co [Complication], patient attitude, perinatal infection/co [Complication], prematurity/co [Complication], priority journal, protein function, syphilis, tuberculosis/dt [Drug Therapy], virus load, antiretrovirus agent/it [Drug Interaction], antiretrovirus agent/dt [Drug Therapy], cytochrome P450/ec [Endogenous Compound], isoniazid/cb [Drug Combination], isoniazid/it [Drug Interaction], isoniazid/dt [Drug Therapy], lamivudine/dt [Drug Therapy], lamivudine/pk [Pharmacokinetics], nevirapine/ae [Adverse Drug Reaction], nevirapine/cr [Drug Concentration], nevirapine/do [Drug Dose], nevirapine/it [Drug Interaction], nevirapine/dt [Drug Therapy], nevirapine/ig [Intragastric Drug Administration], nevirapine/pk [Pharmacokinetics], rifampicin/cb [Drug Combination], rifampicin/it [Drug Interaction], rifampicin/dt [Drug Therapy], virus DNA/ec [Endogenous Compound], virus RNA/ec [Endogenous Compound], zidovudine/it [Drug Interaction], zidovudine/dt [Drug Therapy], zidovudine/iv [Intravenous Drug Administration], zidovudine/pk [Pharmacokinetics], AIDS patient, cytomegalovirus infection, disease severity, disease transmission, drug absorption, drug clearance, drug dose titration, drug metabolism, female, gastrointestinal absorption, genotype, gestational age, high risk patient, Letter

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/28867
Journal of Paediatrics and Child Health
LibKey Link

المؤلفون: Teh J., Murphy D.G., Azad A., Siva S., Alghazo O., Sathianathen N., Thangasamy I.A., Kwan E.M.

مصطلحات الفهرس: ischemic heart disease/si [Side Effect], liver toxicity/si [Side Effect], low drug dose, note, practice guideline, priority journal, prostate cancer/dt [Drug Therapy], quality of life, rash/si [Side Effect], risk reduction, seizure/si [Side Effect], survival time, systemic therapy, urologist, abiraterone/ae [Adverse Drug Reaction], abiraterone/cb [Drug Combination], abiraterone/dt [Drug Therapy], overall survival, prednisone/cb [Drug Combination], prednisone/do [Drug Dose], prednisone/dt [Drug Therapy], metastatic hormone sensitive prostate cancer/dt [Drug Therapy], androgen deprivation therapy, cancer combination chemotherapy, cancer survival, cognitive defect/si [Side Effect], dose response, drug efficacy, drug monitoring, drug safety, fatigue/si [Side Effect], human, hyperglycemia/si [Side Effect], hypertension/si [Side Effect], hypokalemia/si [Side Effect], hypothyroidism/si [Side Effect], abiraterone/po [Oral Drug Administration], apalutamide/ae [Adverse Drug Reaction], apalutamide/dt [Drug Therapy], apalutamide/po [Oral Drug Administration], docetaxel/dt [Drug Therapy], enzalutamide/ae [Adverse Drug Reaction], enzalutamide/dt [Drug Therapy], enzalutamide/po [Oral Drug Administration], prednisolone/ae [Adverse Drug Reaction], prednisolone/dt [Drug Therapy], Note

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/35405
BJU International
LibKey Link

المؤلفون: Chew C.Y., Saracino A.M., Nikpour M., Mar A.

مصطلحات الفهرس: drug absorption, drug bioavailability, drug contraindication, drug efficacy, drug metabolism, drug safety, erythema annulare centrifugum/si [Side Effect], erythema multiforme/si [Side Effect], eye examination, gastrointestinal symptom/si [Side Effect], giant cell granuloma/dt [Drug Therapy], glioblastoma/dt [Drug Therapy], glucose 6 phosphate dehydrogenase deficiency, granuloma annulare/dt [Drug Therapy], heart protection, heartburn/si [Side Effect], human, hyperpigmentation/si [Side Effect], hypertransaminasemia/si [Side Effect], hypoglycemia/si [Side Effect], immunomodulation, irritability, leukopenia/si [Side Effect], lichen (disease)/dt [Drug Therapy], lichen planus/dt [Drug Therapy], lichen sclerosus et atrophicus/dt [Drug Therapy], liver toxicity/si [Side Effect], lung cancer/dt [Drug Therapy], lupus vulgaris/dt [Drug Therapy], measles like rash/si [Side Effect], melanoma/dt [Drug Therapy], mood change, morphea/dt [Drug Therapy], mucinosis/dt [Drug Therapy], multiple myeloma/dt [Drug Therapy], nausea/si [Side Effect], necrobiosis lipoidica/dt [Drug Therapy], nightmare/si [Side Effect], nonhuman, outcome assessment, pancreas cancer/dt [Drug Therapy], panniculitis/dt [Drug Therapy], patient monitoring, pharmacodynamics, photodermatosis/dt [Drug Therapy], porphyria cutanea tarda/dt [Drug Therapy], practice guideline, pregnancy, prescription, pruritus/si [Side Effect], psoriasis/si [Side Effect], rash/si [Side Effect], retina maculopathy/si [Side Effect], retinopathy/si [Side Effect], review, risk benefit analysis, risk reduction, sarcoma/dt [Drug Therapy], side effect/si [Side Effect], skin contusion/si [Side Effect], skin sarcoidosis/dt [Drug Therapy], smoking, solid malignant neoplasm/dt [Drug Therapy], Stevens Johnson syndrome/si [Side Effect], systemic lupus erythematosus/dt [Drug Therapy], systemic sclerosis/dt [Drug Therapy], toxic epidermal necrolysis/si [Side Effect], treatment response, urticaria/si [Side Effect], vasculitis/dt [Drug Therapy], visual impairment/si [Side Effect], vomiting/si [Side Effect], cyclosporine/it [Drug Interaction], digoxin/it [Drug Interaction], glucose 6 phosphate dehydrogenase/ec [Endogenous Compound], hydroxychloroquine/ae [Adverse Drug Reaction], hydroxychloroquine/it [Drug Interaction], hydroxychloroquine/dt [Drug Therapy], hydroxychloroquine/pk [Pharmacokinetics], hydroxychloroquine/pd [Pharmacology], methotrexate/it [Drug Interaction], follicular mucinosis/dt [Drug Therapy], lichen planopilaris/dt [Drug Therapy], reticular erythematous mucinosis/dt [Drug Therapy], urticarial vasculitis/dt [Drug Therapy], laboratory test, abdominal distension/si [Side Effect], acute generalized exanthematous pustulosis/si [Side Effect], agranulocytosis/si [Side Effect], alopecia/si [Side Effect], alopecia areata/dt [Drug Therapy], anorexia/si [Side Effect], antineoplastic activity, antiphospholipid syndrome/dt [Drug Therapy], antithrombotic activity, aplastic anemia/si [Side Effect], blood toxicity/si [Side Effect], chronic urticaria/dt [Drug Therapy], dermatology, dermatomyositis/dt [Drug Therapy], diarrhea/si [Side Effect], DRESS syndrome/si [Side Effect], Review

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/35375
Australasian Journal of Dermatology
LibKey Link

المؤلفون: Sander P., Chu V.H., Durack D.T., Fortes C.Q., Fowler V., Krachmer A.W., Wilson W.R., Stewart R., Herwaldt L.A., Widmer A., Brown Elliot B.A., Falk V., Halbe M., Scriven J.E., Sax H., van Ingen J., Mestres C.A., Diekema D., Brown-Elliott B.A., Wallace R.J., Baddour L.M., Miro J.M., Hoen B., Athan E., Bayer A., Barsic B., Stuart R.L., Hasse B., Hannan M.M., Keller P.M., Maurer F.P., Sommerstein R., Mertz D., Wagner D., Fernandez-Hidalgo N., Nomura J., Manfrin V., Bettex D., Hernandez Conte A., Durante-Mangoni E., Tang T.H.-C., Lundgren J., Gordon S., Jarashow M.C., Schreiber P.W., Niemann S., Kohl T.A., Daley C.L., Stewardson A.J., Whitener C.J., Perkins K., Plachouras D., Lamagni T., Chand M., Freiberger T., Zweifel S., Corey G.R., Schulthess B.

مصطلحات الفهرس: patient care, perfusionist, perioperative period, peripheral neuropathy/si [Side Effect], positron emission tomography-computed tomography, postoperative infection/co [Complication], postoperative infection/di [Diagnosis], postoperative infection/dt [Drug Therapy], postoperative infection/pc [Prevention], postoperative infection/su [Surgery], practice guideline, preoperative care, prognosis, public health, QT prolongation/si [Side Effect], risk factor, short survey, skin discoloration/si [Side Effect], surgical approach, transesophageal echocardiography, tremor/si [Side Effect], tuberculosis/co [Complication], tuberculosis/di [Diagnosis], tuberculosis/dt [Drug Therapy], tuberculosis/pc [Prevention], tuberculosis/su [Surgery], whole genome sequencing, amikacin/dt [Drug Therapy], azithromycin/ae [Adverse Drug Reaction], azithromycin/dt [Drug Therapy], bedaquiline/ae [Adverse Drug Reaction], bedaquiline/dt [Drug Therapy], clarithromycin/ae [Adverse Drug Reaction], clarithromycin/dt [Drug Therapy], clofazimine/ae [Adverse Drug Reaction], clofazimine/dt [Drug Therapy], ethambutol/ae [Adverse Drug Reaction], ethambutol/dt [Drug Therapy], linezolid/ae [Adverse Drug Reaction], linezolid/dt [Drug Therapy], moxifloxacin/ae [Adverse Drug Reaction], moxifloxacin/dt [Drug Therapy], rifabutin/ae [Adverse Drug Reaction], rifabutin/dt [Drug Therapy], rifampicin/ae [Adverse Drug Reaction], rifampicin/dt [Drug Therapy], tuberculostatic agent/dt [Drug Therapy], medical device, abnormal body build/si [Side Effect], abdominal pain/si [Side Effect], antimicrobial therapy, arthralgia/si [Side Effect], bloating/si [Side Effect], bone marrow suppression/si [Side Effect], cardiac surgeon, cardiopulmonary bypass, cardiovascular infection/co [Complication], cardiovascular infection/di [Diagnosis], cardiovascular infection/dt [Drug Therapy], cardiovascular infection/pc [Prevention], cardiovascular infection/su [Surgery], chorioretinitis/co [Complication], chorioretinitis/di [Diagnosis], chorioretinitis/pc [Prevention], chorioretinitis/su [Surgery], clinical feature, conflict of interest, diagnostic imaging, diarrhea/si [Side Effect], dizziness/si [Side Effect], drug fever/si [Side Effect], drug hypersensitivity/si [Side Effect], drug induced disease, drug monitoring, early diagnosis, electrolyte disturbance/si [Side Effect], eye disease/si [Side Effect], eye examination, eye infection/co [Complication], eye infection/di [Diagnosis], eye infection/dt [Drug Therapy], eye infection/pc [Prevention], eye infection/su [Surgery], flu like syndrome/si [Side Effect], follow up, gastrointestinal symptom/si [Side Effect], gastrointestinal toxicity/si [Side Effect], headache/si [Side Effect], hearing impairment/si [Side Effect], high risk population, histopathology, hospital patient, human, immune reconstitution inflammatory syndrome/co [Complication], immune reconstitution inflammatory syndrome/di [Diagnosis], immune reconstitution inflammatory syndrome/pc [Prevention], infection control, infection prevention, infection risk, infectious disease specialist, insomnia/si [Side Effect], iridocyclitis/si [Side Effect], jaundice/si [Side Effect], laboratory test, lactic acidosis/si [Side Effect], liver toxicity/si [Side Effect], medical society, microbiological examination, microbiology, molecular diagnosis, morbidity, mortality, multidisciplinary team, Mycobacterium chimaera, myopathy/si [Side Effect], nausea/si [Side Effect], neurologic disease/si [Side Effect], ophthalmologist, pancreatitis/si [Side Effect], Short Survey

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/28913
Journal of Hospital Infection
LibKey Link

المؤلفون: Zhang M., Borland M.L., Furyk J., Bonisch M., Neutze J., Donath S., Francis K.L., Babl F.E., Oakley E., Brabyn C., Kochar A., Dalziel S.R., Sharpe C., Harvey A.S., Davidson A., Craig S., Phillips N., George S., Rao A., Cheng N.

مصطلحات الفهرس: levetiracetam/cm [Drug Comparison], levetiracetam/dt [Drug Therapy], levetiracetam/os [Intraosseous Drug Administration], levetiracetam/iv [Intravenous Drug Administration], phenytoin/ae [Adverse Drug Reaction], phenytoin/ct [Clinical Trial], phenytoin/cm [Drug Comparison], phenytoin/dt [Drug Therapy], phenytoin/os [Intraosseous Drug Administration], phenytoin/iv [Intravenous Drug Administration], purple glove syndrome/si [Side Effect], dbl phenytoin, hypotension/si [Side Effect], adolescent, allergic reaction/si [Side Effect], article, attributable risk, bleeding/co [Complication], bleeding/dt [Drug Therapy], child, controlled study, death, emergency ward, encephalitis/co [Complication], encephalitis/dt [Drug Therapy], epileptic state/dt [Drug Therapy], extravasation/si [Side Effect], female, heart arrhythmia/si [Side Effect], human, infant, intention to treat analysis, liver toxicity/si [Side Effect], major clinical study, male, open study, pancytopenia/si [Side Effect], priority journal, randomized controlled trial, seizure/dt [Drug Therapy], skin edema/si [Side Effect], Stevens Johnson syndrome/si [Side Effect], benzodiazepine/ae [Adverse Drug Reaction], benzodiazepine/dt [Drug Therapy], levetiracetam/ae [Adverse Drug Reaction], levetiracetam/ct [Clinical Trial], Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/27373
The Lancet
Click here for full text options
LibKey Link

المؤلفون: Tykodi S.S., Carducci M.A., Heng D.Y.C., Kollmannsberger C.K., Harrison M.R., Tomita Y., Duran I., Grunwald V., McHenry M.B., Mekan S., Tannir N.M., Motzer R.J., Rini B.I., McDermott D.F., Aren Frontera O., Salman P., Escudier B., Beuselinck B., Amin A., Porta C., George S., Neiman V., Bracarda S., Hammers H.J., Barthelemy P., Leibowitz-Amit R., Plimack E.R., Oosting S.F., Redman B., Melichar B., Powles T., Nathan P., Oudard S., Pook D., Choueiri T.K., Donskov F., Grimm M.-O., Gurney H.

مصطلحات الفهرس: lung disease/si [Side Effect], lung infection/si [Side Effect], maculopapular rash/si [Side Effect], major clinical study, median survival time, mouth inflammation/si [Side Effect], multicenter study, multiple cycle treatment, multiple organ failure/si [Side Effect], nausea/si [Side Effect], neutrophil count, open study, overall survival, pancreatitis/si [Side Effect], patient risk, phase 3 clinical trial, platelet count, pneumonia/si [Side Effect], priority journal, progression free survival, randomized controlled trial, rash/si [Side Effect], renal cell carcinoma/dt [Drug Therapy], side effect/si [Side Effect], skin disease/si [Side Effect], skin exfoliation/si [Side Effect], skin pruritus/si [Side Effect], stomatitis/si [Side Effect], thrombocytopenia/si [Side Effect], thyroiditis/si [Side Effect], urticaria/si [Side Effect], vomiting/si [Side Effect], alanine aminotransferase/ec [Endogenous Compound], aminotransferase/ec [Endogenous Compound], aspartate aminotransferase/ec [Endogenous Compound], bilirubin/ec [Endogenous Compound], creatinine/ec [Endogenous Compound], gamma glutamyltransferase/ec [Endogenous Compound], ipilimumab/ae [Adverse Drug Reaction], ipilimumab/ct [Clinical Trial], ipilimumab/cb [Drug Combination], ipilimumab/cm [Drug Comparison], ipilimumab/dt [Drug Therapy], ipilimumab/iv [Intravenous Drug Administration], nivolumab/ae [Adverse Drug Reaction], nivolumab/ct [Clinical Trial], nivolumab/cb [Drug Combination], nivolumab/cm [Drug Comparison], nivolumab/dt [Drug Therapy], nivolumab/iv [Intravenous Drug Administration], sunitinib/ae [Adverse Drug Reaction], sunitinib/ct [Clinical Trial], sunitinib/cm [Drug Comparison], sunitinib/dt [Drug Therapy], sunitinib/po [Oral Drug Administration], colitis/si [Side Effect], acute kidney failure/si [Side Effect], adrenal insufficiency/si [Side Effect], adult, advanced cancer/dt [Drug Therapy], alanine aminotransferase blood level, anemia/si [Side Effect], aplastic anemia/si [Side Effect], article, aspartate aminotransferase blood level, asthenia/si [Side Effect], bilirubin blood level, blister/si [Side Effect], bronchitis/si [Side Effect], controlled study, creatinine blood level, creatinine clearance, diabetes mellitus/si [Side Effect], diarrhea/si [Side Effect], drug efficacy, drug response, drug safety, drug withdrawal, dysgeusia/si [Side Effect], dyspepsia/si [Side Effect], eczema/si [Side Effect], endocrine disease/si [Side Effect], erythema/si [Side Effect], fatigue/si [Side Effect], gastrointestinal disease/si [Side Effect], gastrointestinal hemorrhage/si [Side Effect], hand foot syndrome/si [Side Effect], heart arrest/si [Side Effect], heart failure/si [Side Effect], hemophagocytic syndrome/si [Side Effect], human, hypertension/si [Side Effect], hyperthyroidism/si [Side Effect], hypertransaminasemia/si [Side Effect], hypophysitis/si [Side Effect], hypopigmentation/si [Side Effect], hypothyroidism/si [Side Effect], interactive voice response system, intermediate risk patient, kidney disease/si [Side Effect], leukocyte count, liver disease/si [Side Effect], liver metastasis/co [Complication], liver metastasis/di [Diagnosis], liver toxicity/si [Side Effect], loss of appetite/si [Side Effect], Article

URL: The Lancet Oncology
Click here for full text options
LibKey Link